Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model.
The cynomolgus macaque was used as a model to study lipoprotein(a) (Lp(a)). Antibodies to Lp(a) were used in Ouchterlony and Western blot analysis to show that cynomolgus monkey and human Lp(a) were similar immunochemically. Monkey Lp(a) levels were measured by a quantitative sandwich enzyme-linked immunosorbent assay in 117 animals, and Lp(a) varied in concentration from 1 to 64 mg/dl. Individual monkeys had apo(a) glycoprotein sizes as either single- or double-band phenotypes that ranged from 400 to 750 kDa. Monkey apo(a) transcript lengths varied from 8.5 to 13.6 kilobases. The Lp(a) concentration, apo(a) glycoprotein size, and apo(a) transcript length distributions were similar to those in humans. In the monkeys, there was a very high correlation between apo(a) transcript size and apo(a) protein size (R = 0.93, p = 0.0001). This variation in apo(a) transcript and protein size was shown to be due to the number of kringle IV repeats in apo(a) mRNA and DNA. Monkey plasma Lp(a) concentrations correlated inversely with apo(a) glycoprotein size (R = 0.43, p = 0.0016) and directly with hepatic apo(a) mRNA abundance (R = 0.54, p = 0.004). Apo(a) transcript lengths did not correlate with hepatic apo(a) mRNA levels. This suggests that apo(a) size and mRNA levels have major independent effects on plasma Lp(a) concentration. In multivariate analysis, they account for up to 58% of the variability in Lp(a) concentration. In summary, these data provide insight into the regulation of Lp(a) levels and suggest that the cynomolgus monkey is a suitable model in which to study the role of Lp(a) in the pathogenesis of atherosclerosis.
Azrolan
N
N
Laboratory of Biochemical Genetics and Metabolism, Rockefeller University, New York, New York 10021.
Gavish
D
D
Breslow
J L
JL
D000818:Animals; D001053:Apolipoproteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D053241:Apoprotein(a); D015152:Blotting, Northern; D015153:Blotting, Western; D015870:Gene Expression; D007118:Immunoassay; D017270:Lipoprotein(a); D008074:Lipoproteins / Q000097:blood* / Q000737:chemistry; D008099:Liver / Q000502:physiology; D008252:Macaca fascicularis; D008970:Molecular Weight; D012333:RNA, Messenger / Q000737:chemistry / Q000235:genetics; D014018:Tissue Distribution
D001053:Apolipoproteins; D017270:Lipoprotein(a); D008074:Lipoproteins; D012333:RNA, Messenger; D053241:Apoprotein(a)